Pulmonx Corp
Develops minimally invasive treatments for severe obstructive lung diseases.
LUNG | US
Overview
Corporate Details
- ISIN(s):
- US7458481014
- LEI:
- Country:
- United States of America
- Address:
- 700 CHESAPEAKE DRIVE, 94063 REDWOOD CITY
- Website:
- https://pulmonx.com/
- Sector:
- Manufacturing
Description
Pulmonx Corp. is a medical technology company specializing in interventional pulmonology and minimally invasive treatments for severe obstructive lung diseases. The company's core offering is the Zephyr Endobronchial Valve, a non-surgical treatment for patients with severe emphysema, a form of Chronic Obstructive Pulmonary Disease (COPD). The Zephyr Valve is a small, one-way valve implanted in the airways via a bronchoscopic procedure. It is designed to reduce hyperinflation (trapped air) in diseased parts of the lung, alleviating a primary cause of breathlessness. This one-time procedure is clinically proven to improve lung function, exercise capacity, and quality of life. Pulmonx also provides diagnostic and planning tools to support physicians in patient selection and treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Pulmonx Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pulmonx Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pulmonx Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
